C07K 14/80
Cytochromes
C07K14/80 (Cytochromes) appears on 73 US grants and 88 published applications in this corpus.
Search patents in C07K- Granted patents
- 73
- Published applications
- 88
- Assignees
- 71
- Inventors
- 259
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 0 | 2 |
| 2002 | 3 | 2 |
| 2003 | 0 | 3 |
| 2004 | 1 | 5 |
| 2005 | 1 | 4 |
| 2006 | 1 | 6 |
| 2007 | 1 | 1 |
| 2008 | 2 | 7 |
| 2009 | 2 | 3 |
| 2010 | 3 | 5 |
| 2011 | 3 | 3 |
| 2012 | 2 | 2 |
| 2013 | 1 | 1 |
| 2014 | 4 | 4 |
| 2015 | 3 | 2 |
| 2016 | 0 | 2 |
| 2017 | 2 | 4 |
| 2018 | 1 | 4 |
| 2019 | 2 | 3 |
| 2020 | 3 | 6 |
| 2021 | 3 | 4 |
| 2022 | 4 | 8 |
| 2023 | 3 | 1 |
| 2024 | 1 | 4 |
| 2025 | 3 | 2 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Systems and methods for forming biological nanowires and applications thereof28 Apr 2026US 12,612,434 B2Yale University
- Cellular models of and therapies for ocular diseases31 Mar 2026US 12,590,320 B2Reflection Biotechnologies Limited
- Recombinant adeno-associated viral vectors for treating Bietti Crystalline Dystrophy29 Jul 2025US 12,371,474 B2Shanghai Vitalgen Biopharma Co., Ltd.
- P450-BM3 variants with improved activity22 Jul 2025US 12,365,882 B2Codexis, Inc.
- Microorganism for producing L-amino acid having increased cytochrome C activity, and L-amino acid production method using same8 Jul 2025US 12,351,846 B2Cj Cheiljedang Corporation
- Novel p450-bm3 variants with improved activity23 Oct 2025US 2025/0327042 A1Codexis, Inc.
- Biosynthesis of oxygenated hydrocarbons6 Mar 2025US 2025/0075243 A1Ginkgo Bioworks, Inc.
- Recombinant adeno-associated viral vectors for treating bietti crystalline dystrophy19 Sep 2024US 2024/0309068 A1Shanghai Vitalgen Biopharma Co., Ltd.
- Polynucleotides, polypeptides, recombinant cells and methods for generating ergolines and precursors and metabolites thereof15 Aug 2024US 2024/0271170 A1TryptageniX, Inc.
- Recombinant lactate dehydrogenase and uses thereof2 May 2024US 2024/0141303 A1B. G. Negev Technologies and Applications Ltd., At Ben-Gurion University
Most cited
By later US patents
- Transgenic animals for assessing drug metabolism and toxicity48US 7,759,541 B2ITI Life Sciences · 2010
- Method of making double-stranded DNA sequences33US 5,132,215 AEastman Kodak Company · 1992
- Product and process for T cell regulation29US 5,820,866 ANational Jewish Center for Immunology and Respiratory Medicine · 1998
- Protein size marker ladder27US 5,449,758 ALife Technologies Corporation · 1995
- Compositions and methods for treating malaria with cupredoxin and cytochrome23US 7,338,766 B2The Board of Trustees of the University of Illinois · 2008